Characterizing Psychological Consequences of Childhood Trauma
|ClinicalTrials.gov Identifier: NCT00209105|
Recruitment Status : Completed
First Posted : September 21, 2005
Last Update Posted : November 13, 2013
|Condition or disease||Intervention/treatment|
|Major Depressive Disorder||Drug: DEX-CRF stimulation test Behavioral: Psychosocial stress induction Procedure: Brain imaging of sad mood , self-reference, reward Behavioral: Acoustic startle|
This primary goal of this Center is to characterize the neurobiological consequences of early-life trauma. The Center comprises 6 projects that include human subjects. Human subjects are recruited through Project 6.
Project 2: Psychoimmunology (PI A.H. Miller) Project 4: A Model of Learned Safety(PI: M. Davis) Project 6: Clinical Psychobiology(PI: C. Heim) Project 7: Children of Depressed Mothers(PI: Z. Stowe) Project 8: Functional Brain Imaging (PIs: H.S. Mayberg, G. Berns) Project 9: Structural & Anatomical Connectivity Studies (PI: C.Kilts, X. Hu).
Project 2: The study seeks to examine the impact of psychosocial stress on neuroendocrine and immune signaling pathways of adult men and women with and without major depression who have experienced serious trauma (abuse, loss) during development. Serial blood samples will be collected at baseline and after an acute speech/math stressor (see Project 6). Assessments include IL-1alpha, and beta, IL-6, TNF alpha as well as DNS binding of relevant neuroendocrine-immune transcription factors, i.e. GR, CREB, and NFkB.
Project 4: This study uses a model of that allows for the independent evaluation of excitation and inhibition of fear-conditioning measured with the acoustic startle reflex. In addition, a dark-enhanced startle paradigm will be used that tests for anxiety. The effects of early-life stress will be evaluated in humans with and without major depressive disorder.
Project 6: This study assesses neuroendocrine and autonomic responses to stress and pharmacological challenge in subjects with and without major depression who have or have nor experienced early life stress. We seek to identify causes of variability in neuroendocrine-autonomic outcome after early life stress. To achieve this principle aim, we study the role of moderating and mediating factors including gender, genotype, type/timing of childhood trauma, as well as the role of adulthood trauma, comorbidity and cognitive dysfunction. The projects serves as a human subjects core for the other projects.
Project 7: This project characterizes effects of maternal depression on offspring in a longitudinal study. Women with and without depression will be prospectively followed through pregnancy and the first 6 months post-partum. Maternal stress and psychopathology, pregnancy and birth complications, medications and infants' physiological and behavioral stress responses will be assessed.
Project 8: This study uses PET and fMRI to characterize the impact of early-life stress on functional neural pathways mediating mood reactivity, self reference and reward-processing in patients with major depression. Cortical-limbic-striatal changes in cases with early stress but no psychopathology that define vulnerability to depression are also identified.
Project 9: This Project uses data obtained in Project 8 as well as diffusion tensor imaging to define the influence of early-life trauma on brain anatomical and functional connectivity.
|Study Type :||Observational|
|Actual Enrollment :||113 participants|
|Official Title:||Emory Conte Center for the Neuroscience of Mental Disorders: Psychobiology of Childhood Trauma|
|Study Start Date :||January 2005|
|Primary Completion Date :||December 2009|
|Study Completion Date :||March 2011|
Participants who have experienced early-life trauma will undergo a series of diagnostic tests.
Drug: DEX-CRF stimulation test
1 ug/kg body weight of CRF for determining hpa response post dexamethasone ingestionBehavioral: Psychosocial stress induction
Laboratory stress induction, no drug administrationProcedure: Brain imaging of sad mood , self-reference, reward
Brain imagingBehavioral: Acoustic startle
No drugs involved
- Pathophysiological pathways (e.g., blood chemicals, physiological measures, brain images, behavioral measures), as assessed by diagnostic tests [ Time Frame: Measured at Day 2.5 ]
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00209105
|United States, Georgia|
|General Clinical Research Center at Emory University Hospital|
|Atlanta, Georgia, United States, 30322|
|Principal Investigator:||Becky Kinkead, PhD||Emory University SOM - Dept. of Psychiatry and Behavioral Sciences|